Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

VentriPoint Diagnostics Ltd V.VPT

Alternate Symbol(s):  VPTDF

Ventripoint Diagnostics Ltd. is a Canada-based medical device company. It is engaged in the development and commercialization of diagnostic tools to monitor patients with heart disease. It develops a suite of applications for all heart diseases and imaging modalities, including congenital heart disease, pregnancy, pulmonary hypertension, COVID-19, technically difficult imaging and cardiotoxicity in oncology patients. It provides application of artificial intelligence to echocardiography. Its flagship product, Ventripoint Medical System (VMS+), enhances echocardiography to deliver cMRI levels of accuracy for volumetric measurements and ejection fractions for all four chambers of the heart. It has developed a solution that transforms cardiac care through its 3D ECHO and MRI software. VMS products are powered by its proprietary Knowledge Based Reconstruction technology, which is the result of a decade of development and provides accurate volumetric cardiac measurements equivalent to MRI.


TSXV:VPT - Post by User

Comment by WalkOverTheStrton Aug 29, 2023 10:03pm
79 Views
Post# 35611125

RE:second quarter numbers

RE:second quarter numbersMaybe join an investor call vs be suprised... Alvira stated Q2 would be exactly this at the last two investor qtr calls and yet people post here like it's news.
Next one is below. She stated Q4 is when they expect sales traction to hit and has stuck to this the last two calls..

Toronto, Ontario – The Newswire – August 25,  2023 - Ventripoint Diagnostics Ltd. ("Ventripoint" or the "Company"), (TSXV:VPT) (OTC:VPTDF) is pleased to announce that it will release its second-quarter financial results for 2023 on Tuesday, August 29, 2023, after close of market.  Ventripoint will host a webinar/conference call at 11:00 a.m. (EST) on Wednesday, September 6, 2023, to discuss its Q2 2023 financial results and to provide an update on sales and marketing activities.  Details of the webinar/conference call are as follows:

PARTICIPANT TELEPHONE NUMBERS

   

Participant Link: https://www.c-meeting.com/web3/joinTo/3WYDHYDEHKKUTR/-Ex5Yhj0J28VjV9fPfIbZw

   

Alternatively, if participant does not have Internet, please call:

   

Canada/US Toll Free: 1-844-763-8274

   

International Toll: +1-647-484-8814


<< Previous
Bullboard Posts
Next >>